Pfizer Buys InnoPharma As It Buffs Up Established Pharma Unit
This article was originally published in The Pink Sheet Daily
Executive Summary
The big pharma will acquire privately held InnoPharma for $225 million upfront for its rich pipeline of generic injectables and ophthalmic products.